Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001088
Abstract: her schizophrenia decreased, her negative symptoms were controlled, and she did not have the adverse effects of risperidone. At the age of 26 years, when last admitted, the patient was given a 400-mg aripiprazole LAI.…
read more here.
Keywords:
patients concomitant;
psychosis;
aripiprazole lai;
use disorder ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "BMC Pharmacology & Toxicology"
DOI: 10.1186/s40360-019-0330-x
Abstract: BackgroundLong-acting injectable (LAI) antipsychotics for psychotic disorders provide advantages in treatment compliance, but data on their use in pregnancy are very limited. We present a clinical case of aripiprazole LAI use in pregnancy.Case presentationA 43-year-old…
read more here.
Keywords:
pregnancy;
use;
aripiprazole lai;
case ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical Psychopharmacology and Neuroscience"
DOI: 10.9758/cpn.2020.18.1.49
Abstract: Objective To improve poor medication adherence in schizophrenic patients, long-acting injectable (LAI) antipsychotics are used. However, it has not yet become common in Japan. Recently, aripiprazole LAI was approved for alternative injection into the deltoid…
read more here.
Keywords:
long acting;
muscle;
gluteal;
aripiprazole lai ... See more keywords